<DOC>
	<DOC>NCT00668044</DOC>
	<brief_summary>This was a non randomised, multi center, italian study performed in burn patients receiving an antibiotic (ciprofloxacin) in order to treat an active infection. The aim of the study was to validate a pharmacokinetics model useful to verify if a standard dose regimen of ciprofloxacin, given to patients with a compromised metabolism, is a correct dose or instead is over or under dosed.</brief_summary>
	<brief_title>Ciprofloxacin on Burned Patients</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Moderate to severe burnt patients defined as burning of 20 to 60% of total body surface according to rule of nine, II deep degree and III degree according to FullThickness Burn model, Hospitalization for burning injury since at least 72h during hyper metabolic phase Active infections microbiological confirmed Signed informed consent Pregnant or lactating female patients Previous history of tendinopathy Knowing syndrome of QTc prolongation Impairment renal function Hepatic insufficiency Convulsion Limited life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Ciprofloxacin regimen in compromised patients</keyword>
	<keyword>Ciprofloxacin</keyword>
	<keyword>Burned patients</keyword>
</DOC>